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The age-related changes of immune system functions are complex phenomena incompletely understood. The
acquired immune system shows a functional decline in ability to respond to new pathogens during aging, whereas
serum levels of inflammatory cytokines are increased with age. The source of this age-related systemic chronic
inflammation, named inflammaging, was mainly attributed to the progressive activation of immune cells over time.
However, recent studies have shown that the process of cellular senescence can be an important additional
contributor to chronic inflammation, since senescent cells acquire a phenotype named “senescence-associated
secretory phenotype” (SASP), characterized by the enhanced secretion of many inflammation modulators.
Pathogen-associated molecular pattern receptors, in particular Toll-like receptors (TLRs), are key molecules in the
response of innate immunity cells to pathological stimuli. An intriguing and innovative hypothesis is that the
dysfunction of TLRs signaling and the acquisition of SASP can be two interconnected phenomena. The TLR family,
including receptors and co-effector molecules, do not show a consistent age-dependent change across model
systems. However, there is evidence for impaired downstream signaling events, including inhibition of positive and
activation of negative modulators of TLR signaling. MicroRNAs (miRNAs) are a newly discovered class of gene
regulators acting as post-transcriptional repressors of a number of genes. The miRNA property to finely-tune gene
expression makes them right for immune system regulation, which requires precise control for proper activity. We
reviewed evidences suggesting that miRNAs can modulate TLR signaling mainly by three different mechanisms:
1) miRNAs can directly target components of the TLR signaling system, 2) miRNA expression can be directly
regulated by TLRs pathway activation and 3) miRNAs can directly activate the RNA-sensing TLRs, like TLR-8, in
humans. We also reviewed how TLR signaling is modulated by miRNAs during aging, and how an impaired
miRNAs/TLR signaling interaction in immune system cells and related cells, i.e. endothelial cells and adipocytes, can
contribute to inflammaging observed in normal aging. Interestingly, this impairment appears accelerated in
presence of the majors age-related diseases, such as cardiovascular diseases, diabetes, neurodegenerative diseases
and cancers.
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reproduction in any medium, provided the or(TLRs) are transmembrane proteins of mammalian
cells implicated mainly in the recognition of bacterial and
viral components [1,2]. To date, at least 11 TLRs have been
described in humans. Specifically, TLR-2 can hetero-
dimerize with TLR-1 or TLR-6, and either TLR-1/2
or TLR-2/6 can recognize bacterial lipoproteins, such
as peptidoglycan or lipopeptide; TLR-3 recognizes viral
double-stranded RNA; TLR-4 binds the endotoxin
lipopolysaccharide (LPS) from Gram-negative bacteria;
TLR-5 recognizes bacterial flagella proteins; TLRs-7
and −9 detect pathogenic nucleic acids; TLR-10 canLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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is currently unknown; finally TLR-11 can recognize
molecules from the uro-phatogenic bacteria [2,3]. Thus,
TLR −2, -4 and −6 function as the principal innate sen-
sors for cell-wall components of gram-negative bacteria
in mammals [4]. Viral nucleic acid molecules are recog-
nized by the endosomal TLRs −3, -7, -8, and −9, by the
cytosolic retinoic acid-inducible gene-like receptors
(RLRs) Rig-I and Mda5, and by the dsRNA-dependent
protein kinase R (Pkr) [5]. TLR-3 and the RLRs recog-
nize double stranded RNA (dsRNA) molecules, whereas
TLR −7, -8 and −9 recognize single stranded RNA
(ssRNA) and DNA. The endosomal TLR-7, -8 and −9
signal act via MyD88, whereas TLR-3 uses the TIR do-
main containing adaptor inducing interferon-β (TRIF)
molecule. Thus, all TLRs, with the exception of TLR-3,
require MyD88 to induce phosphorylation of IL-1 recep-
tor associated kinase (IRAK)-1 by IRAK4. Phosphorylated
IRAK1 recruits and activates TNFR-associated factor
6 (TRAF6). TRAF6 can then activate protein kinase C
(PKC), Extracellular Signal Regulated Kinase (ERK)-1/2,
and Transforming Growth Factor (TGF)-β-activated kinase
1 (TAK1). TAK1 is a Mitogen Activated Protein Kinase
(MAPK) able to phosphorylate p38 MAPK, c-Jun
N-terminal kinase (JNK), and I-kappa kinase (IκK). Activa-
tion of IκK leads to the nuclear translocation of Nuclear
Factor kappa-B (NF-κB) and subsequent transcription of
genes associated with TLR activation. NF-kB is a tran-
scriptional regulator consisting of reticuloendotheliosis
(Rel) protein dimers that bind a DNA sequence motif
known as kB site, and it is retained in the cytoplasm by
specific kB inhibitors, such as IkBα, IkBβ, IkBγ, IkBζ,
IkBNS and Bcl-3 [6,7]. Overall, pathogen-derived ligand-
induced TLR engagement and signal transduction leads to
activation of NF-κB and thereby to the induction of pro-
inflammatory and antiviral response genes [8].
More controversial is the potential role of TLRs in the
recognition of endogenous ligands and which effect this
recognition might have on the consequent development
of chronic inflammatory disorders. An increasing num-
ber of studies implicate TLRs as being involved in the
immune response to self-molecules that may be altered
or could be accumulated in non-physiologic sites or
amounts. Prolonged injury induces tissue damage and
generation of endogenous TLR-4 ligands able to activate
TLR-4 signaling, sustaining in turn fibroblast activation
[9]. For example, Herpes simplex virus type 1 (HSV-1)
induces and activates TLR-2 and TLR-4 receptors at the
central nervous system (CNS) both directly, through
interaction of astrocytes with the pathogen, and also in-
directly, by endogenous ligands produced locally, such
as serum amyloid protein [10]. Further, in rheumatoid
arthritis (RA), Snapin (SNAP associated protein) was
identified as a novel endogenous TLR-2 ligand [11]. Theextracellular matrix glycoprotein tenascin-C is an en-
dogenous activator of innate immunity that promotes
the synthesis of inflammatory cytokines via activation of
TLR-4 [12]. Furthermore, the soluble form of the extra-
cellular matrix proteoglycan decorin was demonstrated
to act as an endogenous ligand of TLR −2 and −4,
stimulating the production of proinflammatory mole-
cules in human macrophages [13].
Recent findings have shown increased TLR-2 and −4
expression, signaling, ligands, and functional activation
both in type 1 diabetes mellitus (T1DM) subjects and in
monocytes of type 2 diabetic (T2DM) patients [14]. This
increased activity of TLRs in diabetes seems to be the re-
sult of both endogenous and exogenous ligands [15].
TLR-2 knockout mouse model has been used to show
the important role played by TLRs to promote the pro-
inflammatory state of T1DM and the progression of dia-
betic nephropathy [16].
When it was tested the hypothesis that TLR-4-induced
transcription patterns elicited in humans exposed to
in vivo endotoxin would parallel gene expression pat-
terns observed in trauma patients with initial non-
infectious injury, a group of more than 400 genes that
exhibit similar expression trends in leukocytes derived
from either endotoxin-challenged subjects or trauma pa-
tients was found [17].
Overall, besides the general concept that TLRs are im-
plicated in the recognition of bacterial and viral compo-
nents, many data suggested that TLRs can also play a role
in the recognition of several, not all identified, endogenous
ligands. Recently, it was proposed to name all the en-
dogenous TLRs ligands as damage associated molecular
pattern molecules (DAMPs) [18]. It can be hypothesized
that alterations of TRLs/ligands, both exogenous and en-
dogenous, may contribute to the pathogenesis of human
diseases, especially the major age-related diseases, such as
cardiovascular diseases, diabetes, neurodegenerative dis-
eases and cancers.
Age-related changes in TLR expression in immune system
cells
Age-related human diseases are mainly, or at least in
part, due to numerous changes in the immune system
which result in a significant decline in protective im-
munity [19]. Although it is well documented that both B
and T lymphocyte compartments of the adaptive im-
mune system deteriorate with advancing age, the impact
of aging on many aspects of the innate immune response
remains to be elucidated. In fact, even in the absence of
an immune challenge, healthy-aged individuals have a
significantly higher basal inflammatory state, character-
ized by increased circulating cytokines levels, including
IL-6, IL-1β and TNF-α [20]. This progressive pro-
inflammatory status, termed inflammaging, renders the
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lowing systemic insults [20,21]. Inflammaging is one
of the major driving forces of frailty and of common
severe age-related diseases development and progres-
sion, including cardiovascular diseases, type 2 diabetes
mellitus and neurodegenerative diseases [22,23]. It can
be hypothesized that alteration of TLRs and/or TLR-
ligands expression levels, both exogenous and endogen-
ous, during cellular aging could contribute to such
inflammation imbalance. The age-related expression of
the TLR signaling pathway components have been ex-
tensively studied in cells of the innate immunity, mainly
neutrophils and macrophages. The effect of aging on
these cells appears to be multifaceted, affecting almost
every aspect of their normal cellular function. Myeloid pre-
cursors differentiate into macrophages in the presence of
growth factors such as macrophage-colony stimulating fac-
tor (M-CSF), granulocytes macrophage-colony stimulating
factor (GM-CSF) and IL-3. There is a degree of ambiguity
on how age can effect the generation of macrophages from
their precursor. The number of monocytes in the aged and
young subjects appears to be comparable; however, there is
a significant decrease in macrophage precursors as well as
macrophages in the bone marrow of the elderly [24].
TLRs expression in cells of innate immunity, such as
macrophages, granulocytes and dendritic cells, was ana-
lyzed in vitro and in vivo, both in animal models and in
humans, during aging/senescence processes, showing
complex results.
Age-related TLR expression changes in immune system
cells of animal model
A number of evidences in murine models support the
notion that aging do not affect the expression levels of
TLR. The expression levels of TLR-2, -4 and −6, in ab-
sence of stimulation, was similar in peritoneal macro-
phages, lymphocytes, and macrophages from older and
younger mice [25,26]. However, the sensitivity to re-
peated LPS exposure in cells from young and middle-
aged mice is different and seems to be partly associated
with the different expressions levels of TLR-2 and −4
[27]. LPS is one of the most important virulence factors
of gram-negative bacteria, and plays an essential role in
triggering inflammation. Endotoxin tolerance induced by
repeated LPS stimulations could lead to the reprogram-
ming of the immune system with the aim to obtain a pro-
tective role against inflammatory tissue destruction [28].
The down-regulation of TNF-α and IL-1β, the main pro-
inflammatory cytokines, and the preservation of IL-10, the
main anti-inflammatory cytokine, seem to confirm this hy-
pothesis. In addition, the decreased secretions of TNF-α
and IL-10 by LPS-stimulated peritoneal macrophages
from middle-aged mice, indicates the impaired functions
of TLR −2 and- 4 in these cells, which might be associatedwith the age-related changes in TLR-2 and −4 signaling
transduction [26].
Moreover, total levels of TLR-1 were unaffected by age
whereas TLR-2 surface expression was significantly but
slightly increased in alveolar macrophages from aged
mice, suggesting that intracellular TLR signaling defects,
rather than TLRs expression, were responsible for the
age-related decline in in vivo responsiveness to pneumo-
coccal pneumonia [29]. However, TLR-4 and TLR-5 ex-
pression was reported to be higher in old rhesus
macaques (Macaca mulatta) compared to younger ani-
mals [30].
Overall, no conclusive results can be obtained on TLRs
baseline expression level in animal model during aging.
However, tolerance induced by LPS repeated exposure
seems to be related to age. The lack of response to the
stimulation of LPS and the increased proinflammatory cy-
tokines release observed in macrophages of aged mice
suggest that TLRs signaling transduction is impaired in
cells from aged animals.
Age-related TLR expression changes in human immune
system cells
Recently, the surface expression of TLRs −1, -2, -4, -5,
and −6 from monocytes of younger and older individuals
was quantified by flow cytometry, showing complex re-
sults. It was reported a decreased expression of TLR-1
and TLR-4, unchanged levels of TLR-2 and TLR-6 and a
significant increased expression of TLR-5 in monocytes
from older individuals compared with that of younger
ones [31]. Basal levels of TLR-2 and TLR-4 expression
were previously showed to be unaltered by age on neutro-
phils and monocytes of aged and young donors [32,33].
The production of age-related cytokines following
stimulation with a wide range of TLR ligands has also
been studied in monocytes from young and older do-
nors. While the basal levels of IL-8 and TNF-α were
equivalent between the age groups, macrophage migra-
tion inhibitory factor (MIF) had higher basal levels in
monocytes from older donors [31]. In addition, a higher
representation at baseline of the signaling mediator NF-
κB (p65) translocated to the nucleus of monocytes from
older donors was showed [31]. Interestingly, it was ob-
served a statistically significant stimulation-specific in-
crease in the production of IL-8 by adherent monocytes
from older individuals for all TLR ligands, even if the
magnitude of IL-8 production was highest following
treatment with the TLR-5 ligand, flagellin [31]. Overall,
even if cytokine plasma levels is increased with age, the
production of IL-6 and TNF-α was decreased in macro-
phages from aged compared to young individuals. This
apparent paradox of low cellular production and high
plasma cytokine levels may be resolved by considering
that with age, macrophages remain activated for longer
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[34]. Thus, the ineffective clearance of pathogens by
macrophages can increase the duration of their activa-
tion and contribute to perpetuation of inflammatory re-
sponses during ageing.
In conclusion, gene transcription, protein expression
and cell surface expression of members of the TLR fam-
ily (receptors and co-effector molecules) of innate im-
munity cells do not show a consistent age-dependent
change across immune system models. However, there
is evidence for impaired downstream signaling events,
including inhibition of positive and activation of negative
modulators of TLR induced signaling events.
Age-related changes in TLR expression in non immune
system cells
Interestingly, cells that are not typically involved in the
innate immune response such as T cells, B cells, epithe-
lial cells, endothelial cells, adipocytes, cardiac cells and
others, are able to produce cytokines in response to TLR
ligands interaction.
It was described an age-dependent upregulation of in-
testinal epithelial TLR-3 expression in humans, which
might contribute to rotavirus reduced susceptibility in
adults [35].
We recently showed that also endothelial cells are able to
produce cytokines via TLR signaling. An increased release
of interleukin (IL) -1β, -1α -2, -6, -8, -10, -12, tumor necro-
sis factor (TNF)-α, interferon (INF)-γ and mieloperoxidase
(MPO) were observed in senescent vs. younger human um-
bilical vein endothelial cells (HUVEC) [36]. Moreover, after
LPS stimulation, an increased IL-6 release was observed.
Interestingly, the strength of this effect depends on the sen-
escent status of HUVEC (unpublished data).
Cardiac myocytes express many of the TLRs and li-
gands able to activate TLR-2, TLR-4, and TLR-5 indu-
cing NF-κB activation and IL-6 and intercellular
adhesion molecule (ICAM)-1 expression in vitro [37].
Interestingly, TLRs expression was also studied in
hematopoietic stem cell (HSC). Selective loss of lym-
phopoietic potential in HSC has been seen in studies
of normal aging, and could conceivably contribute to
immunosenescence [38]. However, the mechanism(s)
responsible for HSC aging have only begun to be eluci-
dated [39]. Recent studies have reported epigenetic
changes, accumulation of DNA damage, and increased
levels of intracellular reactive oxygen species in aged
HSCs. Interestingly, HSC from mice are injured by
persistent exposure to small amounts of a single TLR
ligand, such as LPS. Although phenotypically defined
HSCs increased in LPS treated mice, their repopulating
and lymphopoietic potentials dramatically declined
[38]. Thus, low-grade host/pathogen interactions may
be detrimental for stem cells functions over time.Although the TLR expression modulation in adipo-
cytes during aging has not yet been investigated, their
contribution on chronic inflammation, a phenomenon
named as metaflammation, was also highlighted. Recent
studies suggest that adipocytes may play an important
role in the physiological regulation of immune/inflam-
matory responses in fat deposits via TLR signaling cas-
cades [40,41]. Adipocytes are no longer considered
passive cells storing fat, but they share with macro-
phages many biological properties including synthesis
and release of molecules regulating inflammation. Fatty
acid levels, which are elevated in obesity, can induce
both local and systemic inflammation via activation of
TLR [42]. Thus, a positive feedback loop between local
inflammation in adipose tissue and altered immune
response in obesity, may contribute to the development
of obesity-related metabolic complications and the
inhibition of NF-kB signalling pathways could be an ex-
cellent strategy for treatment of metabolic complications
in obese individuals.
TLR signaling modulation via microRNAs
TLR signaling must be stringently regulated in order to
ensure sufficient clearance of pathogens and a timely re-
turn to homeostasis after infection. MiRNAs are a newly
discovered class of gene regulators which bind to the
3′ untranslated region of target mRNA and direct their
post-transcriptional repression. The discovery of miRNAs
has revolutionized the way we examine the regulation of
gene transcription and translation. The special properties
of miRNA to finely-tune gene expression naturally lends
itself to immune system regulation, which requires regula-
tory mechanisms for proper activity.
Evidences were provided suggesting that miRNAs
can modulate TLR signaling mainly by three different
mechanisms: 1) miRNAs can directly target components
of the TLR signaling system, 2) miRNAs expression can
be directly regulated by TLRs and 3) miRNAs can dir-
ectly activate the RNA-sensing Toll-like receptor.
Regarding the first two mechanisms, it is important to
note that several miRNAs have been shown to be up-
regulated in response to TLR ligands, and many of them
directly target components of the TLR signaling system,
revealing a feedback loop control of TLR signaling ac-
tivation. Specific miRNAs were reported to modulate
trascription of receptors, adaptor molecules, and regula-
tor molecules within TLR and IL-1R signaling, through
positive and negative feedback loops. A trio of miRNA,
such as miR-155, miR-21 and miR-146a, have proven to
be key TLR signaling modulators and, importantly, these
miRNas are codified by endotoxin-responsive genes [43].
The role of different miRNAs mainly involved in modu-
lating TLRs pathways is described here and depicted in
Figure 1.
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MiR-146a is known to target key elements of MyD88
signaling pathway, including IRAK1 and TRAF6, modu-
lating in turn the inflammatory responses mediated by
TLR-4, TLR-2 and TLR-5 ligands [44]. Thus, a role for
miR-146a in control of TLR receptor and cytokine sig-
naling through a negative feedback regulation loop in-
volving down-regulation of IRAK1 and TRAF6 protein
levels was proposed [45]. A lot of evidence demonstrated
that miR-146a is critical for endotoxin tolerance ob-
served in in vitro cultured monocytes [46]. Interestingly,
miR-146a, which negatively regulates the expression of
IL-1β and IL-6, was highly expressed in aged mice as a
consequence of an aberrant NF-κB binding to the
miR-146a promoter [47]. As a result, the negative feed-
back regulation loop inducing a down-regulation of in-
flammation factors resulted interrupted in aged mice
[47]. In macrophages isolated from aged mice the DNA
methyl-transferase inhibitor and the histone deacetylase
inhibitor are both able to significantly up-regulate miR-
146a transcriptional activation by altering the DNA-
binding activity of NF-κB. These data suggest that DNA
methylation and histone acetylation are involved in the
suppression of age-dependent miR-146a expression.
Overall, these data indicate that the deregulated expres-
sion of miR-146a contributes to the age-associated dys-
function of macrophages in aged animals [47].
We recently reported that in endothelial cells, such as
HUVEC and in circulating angiogenic cells (CACs)T












Figure 1 MicroRNA (miRs) modulating TLRs pathways. GPI = glycophoderived from monocytic lineage, IRAK1 protein, but not
TRAF6, modulation depends on miR-146a [36]. We also
observed that LPS stimulation induces an increased ex-
pression of miR-146a and that younger cells respond
faster than senescent ones to LPS stimulation, suggesting
a more efficient stimulus-induced response by young
cells (unpublished data).
MiR-155
MiR-155 may control the expression of IKKβ and IKKε,
which leads to repression of NF-κB activation. Its ex-
pression in mature human dendritic cells (DCs), is part
of a negative feedback loop, which down-modulates in-
flammatory cytokine production in response to micro-
bial stimuli [48].
MiR-21
MiR-21 targets PTEN, an inhibitor of AKT, which in
turn activates NF-κB [45]. Another well established
target of miR-21 is the tumor suppressor PDCD4, a
proinflammatory protein that promotes activation of the
transcription factor NF-κB and suppresses interleukin 10
(IL-10) [49]. Transfection of cells with a miR-21 precur-
sor blocked NF-κB activity and promoted the production
of the anti-inflammatory IL-10 in response to LPS. In
addition to PTEN and PDCD4, a number of other tar-
gets of miR-21 including tropomyosin (TPM1), sprouty1






















sphoinositol; RSV= respiratory syncytial virus.
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signaling in mice, suggesting an in vivo role of miR-21 in
suppressing TLR-2 signaling [52]. As reported for
miR-146a, also miR-21 precursor transcript is up-
regulated by NF-kB [53].
Furthermore, our recent findings suggest that circulat-
ing miR-21 may be a new biomarker of inflammation
[54]. Interestingly, non monotonic age-related changes
of miR-21 was observed in different age-groups of
healthy subjects. Mir-21 levels increased mainly in
octogenarian than in centenarins compared to younger
subjects, according with the presence of an highest
chronic inflammation levels in this setting of subjects
[54]. Circulating miR-21 levels were correlated with
C-reactive protein and fibrinogen levels, two well
established biomarkers of inflammation [54].
MiR-126
Tissue inflammation is critically regulated by miR-126
both in vitro and in vivo, via modulation of the expres-
sion of cell adhesion proteins, i.e. VCAM-1 [55]. Mice
with knockdown of miR-126 function showed a renal
inflammation, suggesting that miR-126 plays a major
role in the response of renal microvascular endothelial
cells to systemic inflammatory stimuli [55]. Accordingly,
miR-126 is also deregulated in several disorders charac-
terized by endothelial cell activation in response to sys-
temic inflammatory stimuli, including cardiovascular
diseases, diabetes mellitus and others inflammatory dis-
eases [56]. Interestingly, miR-126 can down-regulates
the expression of IKBβ, an important inhibitor of NF-κB
signaling pathway [56].
Other miRs
Other miRs were reported to be direct or indirect
regulators of molecules belonging to TLRs pathway.
MiR-147, was induced upon stimulation of multiple
TLRs and functioned as a negative regulator of TLR-
associated signaling events in murine macrophages [57].
Recently, TLR-4 activation, has been shown to down-
regulate miR-107 expression in macrophages. In addition,
miR-107 has been demonstrated to be deregulated in
murine and rodent models of obesity and insulin resist-
ance, contributing to both conditions [58]. Under cell
cycle arrest conditions, miR-511 was reported to function
as a positive regulator of TLR-4, whereas under replicative
condition miR-511 seems to inhibit TLR-4 expression in
monocytes and dendritic cells [59]. Recently, miR-200b
and miR-200c were identified as factors that modify the
efficiency of TLR-4 signaling through the MyD88-
dependent pathway and can thus affect host innate de-
fences against microbial pathogens [60]. Recent data also
demonstrated that miR-187 directly targets TNF-α mRNA
and indirectly decreases IL-6 and IL-12p40 expression viadown-modulation of IκBζ, a master regulator of the tran-
scription of these latter two cytokines. These results un-
cover a miRNA-mediated pathway controlling cytokine
expression and demonstrate a central role of miR-187 in
the physiological regulation of IL-10-driven anti-
inflammatory responses [61].
Unconventional role of miRNAs were recently identi-
fied. Since miRNAs are short single strand RNA mole-
cules, they can mimic viral RNA and consequently they
can bind directly to TLRs 7–9, able to detect pathogenic
nucleic acids. MiR let-7 is an highly abundant regulator of
gene expression in the central nervous system and it is not
only expressed in microglia, the major immune cells of
the brain, but also in neurons. It was recently showed that
extracellular let-7 activates the RNA-sensing TLR-7 and
induces neurodegeneration in patients with Alzheimer’s
disease [62]. A similar mechanism of miRNA-induced
TLR activation was reported for miR-21: miR-21 can dir-
ectly bind to TLR-7 in mice and TLR-8 in human macro-
phages, inducing the secretion of TNF-α and IL-6 [63].
Thus, miRNAs can function as agonists of the single-
stranded RNA-binding TLRs, leading to NF-κB signaling
activation and secretion of pro-inflammatory cytokines
[64]. It can be hypothesized that these mechanisms could
be much more widespread than what has been so far
observed.
Overall, most of the miRNAs targeting TLRs pathway
molecules act thought a negative feedback loop aimed to
restrain the excessive pro-inflammatory response induced
by TLR signaling activation. Consequently, a deregulation
of miRNAs targeting TLR signaling molecules, may con-
tribute to an inflammatory-antiinflammatory imbalance.
Moreover, miRs can induce a chronic TLRs pathway ac-
tivation binding directly to RNA-sensible TLRs. As a
consequences, miR-induced TLRs deregulation could
contribute to the development and progression of many
inflammatory diseases, such as the major age-related
diseases, including cardiovascular diseases, diabetes,
Alzheimer and cancers [65].
Cellular senescence and inflammaging: which role for
TLRs pathway activation?
Aging, and especially human aging, can be explained by
the emerging concept of a combination of inflammation
and aging. Aging, either physiological or pathological,
can be driven by pro-inflammatory cytokines and sub-
stances produced by the innate immune system. The
source of this chronic inflammation was mainly attrib-
uted to the progressive activation of immune cells over
time [23]. However, recent studies have shown that the
process of cellular senescence might be itself an im-
portant additional contributor to chronic inflammation
[36,66,67]. Senescent cells can acquire a specific pheno-
type named “senescence-associated secretory phenotype”
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modulators of inflammatory status [66]. Interestingly,
this phenomenon was documented not only in “immune
cells” like macrophages [67,68], but also in fibroblast
[66] and endothelial cells [36,69] (Figure 2).
Emerging data revealed that NF-κB signaling is the
major pathway which stimulates the appearance of SASP
[70,71]. There is a large number of NF-κB activators, and
among them TLR ligands are the most potent [72,73]. In
addition, TNF-α, IL-1, the antigen receptors found on the
adaptive immune cells, specifically the T-cell receptor and
B-cell receptor (TCR and BCR), and receptors found on
antigen presenting cells CD40R can activate TLRs signal-
ing. Furthermore, NF-κB can be activated by growth
factors such as hepatocyte growth factor (HGF), follicle
stimulating hormone (FSH), granulocyte macrophage-
colony stimulating factor (GM-CSF), and nerve growth
factor (NGF) and following DNA damage via mutation of
the DNA response protein ataxia telangiectasia mutated
(ATM), involving NEMO, that activates cytoplasmic IKK
[74]. Genomic instability evoked by cellular stress triggers
epigenetic changes, e.g. release of HMGB1 proteins which
are also potent enhancers of inflammatory responses.
Moreover, environmental stress and chronic inflammation
can stimulate p38MAPK and ceramide signaling and in-
duce cellular senescence with pro-inflammatory responses
[74]. On the other hand, two cyclin-dependent kinase in-
hibitors, p16INK4a and p14ARF, are effective inhibitors of
NF-κB signaling.
Even if many data confirmed the relationship between
SASP and NF-κB signaling activation, few data wereFigure 2 NF-kB activation via TLRs can be induced by the activation o
(SASP).reported on the molecular relationship between TLRs
pathway activation and SASP. We recently reported that
the most hyper-expressed miRNAs in senescent HUVEC
compared to younger cells, target TLRs signaling pathway,
suggesting that a deregulation of TLRs pathway is directly
or indirectly associated with cellular senescence and ac-
quisition of SASP [36]. At the cellular level, both proli-
ferative and/or oxidative-stress induced cell senescence
associated with a pro-inflammatory state may greatly con-
tribute to inflammaging [75]. It was demonstrated that
TLR-2 translates oxidative tissue damage into inflamma-
tory responses by mediating the effects of oxidized phos-
pholipids [76]. Thus, it can be hypothesized that chronic
activation of TLRs by endogenous ligands, i.e. oxidized
phospholipids, in absence of pathogens infection, can pro-
mote the acquisition of SASP both in vivo and in in vitro
cultured cells during replicative senescence.
Overall, we hypothesize that different mechanisms can
contribute to perpetuation of inflammaging: i) the pro-
gressive activation of immune cells over time, ii) the
ineffective clearance of pathogens by aged macrophages
that can increase the duration of their activation via TLRs,
iii) endogenous TLRs ligands released by senescent cells
that can contribute to chronic TLR activation in absence
of pathogens infection, iiii) miRNAs hyper-expressed and
released by senescent cells that can directly activate TLRs
in cells of innate immunity and in endothelial cells.
Conclusion
The aging process is associated with a loss of complexity
in the dynamics of physiological systems that reduce thef immune cells and by the acquisition of senescent phenotypes
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diseases.
An increase of inflammatory markers was described as a
general feature of the ageing process, and thus named
as inflammaging. Inflammaging phenotype is a complex
phenotype which is the result of the age-related cell/tissue
adaptation and remodelling, involving not only innate
but also adaptive immunity, as well as other tissues or or-
gans (gut, fat tissue, liver, muscle, brain). Importantly,
inflammaging appears accelerated in many age-associated
diseases. The source of the age-associated chronic inflam-
mation was mainly attributed to the progressive activation
of immune cells over time and to the acquisition of SASP.
Thus, the accumulation of senescent cells in aged subjects
could contribute to the perpetuation of inflammaging, and
the systemic chronic inflammatory status could, in turn,
contribute to the diseases development. Both phenomena,
the activation of immune cells over time and the accumula-
tion of senescent cells in aged subjects, are strictly related
to TLRs activation. An altered TLRs/ligands interaction
seems to contribute to the impairment of reparative and re-
generative capability of the aged tissues, in normal aging
and mainly in age-related diseases. Increasing evidence sug-
gests that miRNAs could play important roles in this sce-
nario, modulating both TLRs pathway activation and SASP
acquisition. MiRNAs can have two opposite roles: TLR ac-
tivation and NF-kB signalling inhibition, in a complex sce-
nario where low and chronic inflammation prevails, likely
also sustained by cell senescence secretome. MiRNAs in-
hibition effect probably belongs to the different levels of
anti-inflammatory pathways that have evolved to abate
TLR signalling to prevent cell and tissue destruction [77].
To improve our understanding of the contribution of
cellular senescence/SASP to ageing and age-related dis-
ease, it is imperative to define a specific signature of
cellular senescence that is functionally connected with
normal and pathological ageing. Currently, there are
many gaps in our knowledge of the processes leading to
senescence, and the signature of cellular senescence both
in vitro and in vivo [78]. In conclusion, the identification
of a well-defined set of senescence biomarkers for ageing
and age-related disease could have a strong impact on
the diagnosis, staging and predicted outcomes of age-
related disease, providing the basis for a pharmacological
intervention to postpone ageing and age-related disease.Competing interest
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